Preclinical studies have demonstrated that vaccines targeting prostate and prostate cancer-associated antigens can induce immune responses to those antigens and result in protection from ...

The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...

A new vaccine has offered hope to thousands of British men with advanced prostate cancer. UK doctors have produced the first treatment that actually kills prostate cancer cells. Trials are at an ...

Russian President Vladimir Putin first hinted at the possibility of a cancer vaccine in February 2024, claiming that Russian ...

Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase 2b trial of its prostate cancer vaccine RV001 showed it was no more effective than ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of ...

Keck Medicine of USC is conducting a clinical trial that explores using steam as a potential alternative to surgery or ...

In an interview with pharmaphorum, Goodfellow said the backing of CRUK was an endorsement of Scancell and its cancer vaccine platform. After years of failures (most notably prostate cancer vaccine ...